{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,12]],"date-time":"2026-11-12T19:55:44Z","timestamp":1794513344689,"version":"4.9.1"},"reference-count":60,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,11,26]],"date-time":"2025-11-26T00:00:00Z","timestamp":1764115200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,12,30]],"date-time":"2025-12-30T00:00:00Z","timestamp":1767052800000},"content-version":"vor","delay-in-days":34,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100020595","name":"National Science and Technology Council","doi-asserted-by":"publisher","award":["NSTC 114-2410-H-033-027"],"award-info":[{"award-number":["NSTC 114-2410-H-033-027"]}],"id":[{"id":"10.13039\/100020595","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Alz Res Therapy"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Introduction<\/jats:title>\n                    <jats:p>Previous studies on serum lipid levels and cognitive outcomes have shown inconsistent results, partly due to differences in timing of lipid assessment, cognitive status, and lack of longitudinal data. This study aimed to examine both baseline and longitudinal changes in lipid profiles in relation to dementia onset and cognitive progression across different stages of cognitive impairment.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>A retrospective cohort study was conducted using data from the History-Based Artificial Intelligent Clinical Dementia Diagnostic System (HAICDDS), a multicenter memory clinic registry in Taiwan. Among 2,452 adults aged\u2009\u2265\u200960 years, lipid levels (total cholesterol, low-density lipoprotein cholesterol [LDL-c], high-density lipoprotein cholesterol [HDL-c], and triglycerides [TG]) were assessed at baseline and follow-up. Participants were stratified into subjective cognitive decline, mild cognitive impairment, or dementia. Cox proportional hazards models were used to evaluate associations with incident dementia or cognitive progression.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>U-shaped associations were observed between lipid levels and cognitive outcomes. After adjusting for demographic and vascular risk factors, both low baseline values and extreme reductions\u2014particularly in HDL-c and TG\u2014were significantly associated with increased risk of dementia onset or progression.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Lipid instability, especially in HDL-c and TG, may serve as a marker of cognitive vulnerability. These findings suggest that longitudinal changes in serum cholesterol should be carefully monitored in older adults at risk of cognitive decline.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s13195-025-01910-8","type":"journal-article","created":{"date-parts":[[2025,11,26]],"date-time":"2025-11-26T05:55:57Z","timestamp":1764136557000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Baseline and follow-up change of cholesterol levels predict dementia risk and progression in older adults: a U-shaped relationship"],"prefix":"10.1186","volume":"17","author":[{"given":"Pai-Yi","family":"Chiu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hsi-Hsien","family":"Chou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chih-Li","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hsin-Hua","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tzu-Yu","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong-Ming","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hsin-Te","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,11,26]]},"reference":[{"key":"1910_CR1","doi-asserted-by":"publisher","unstructured":"1. Wang R. Global burden of Alzheimer\u2019s disease and other dementias during 1990\u20132021: a Global Burden of Disease and Risk Factors Study 2021-based study. Neuroepidemiology. 2025:1\u201312. https:\/\/doi.org\/10.1159\/000543578.","DOI":"10.1159\/000543578"},{"issue":"11","key":"1910_CR2","doi-asserted-by":"publisher","first-page":"1769","DOI":"10.1002\/alz.12482","volume":"17","author":"A Dove","year":"2021","unstructured":"Dove A, Shang Y, Xu W, et al. The impact of diabetes on cognitive impairment and its progression to dementia. Alzheimers Dement. 2021;17(11):1769\u201378. https:\/\/doi.org\/10.1002\/alz.12482.","journal-title":"Alzheimers Dement"},{"issue":"1","key":"1910_CR3","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1161\/HYPERTENSIONAHA.114.03040","volume":"64","author":"C Iadecola","year":"2014","unstructured":"Iadecola C. Hypertension and dementia. Hypertension. 2014;64(1):3\u20135. https:\/\/doi.org\/10.1161\/HYPERTENSIONAHA.114.03040.","journal-title":"Hypertension"},{"key":"1910_CR4","doi-asserted-by":"publisher","unstructured":"4. Shepardson NE, Shankar GM, Selkoe DJ. Cholesterol level and statin use in Alzheimer disease: I. Review of epidemiological and preclinical studies. JAMA Neurol. 2011;68(10):1239\u20131244. https:\/\/doi.org\/10.1001\/archneurol.2011.203.\u00a0","DOI":"10.1001\/archneurol.2011.203"},{"issue":"4","key":"1910_CR5","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000210247","volume":"104","author":"Z Zhou","year":"2025","unstructured":"Zhou Z, Moran C, Murray AM, et al. Association of year-to-year lipid variability with risk of cognitive decline and dementia in community-dwelling older adults. Neurology. 2025;104(4):e210247. https:\/\/doi.org\/10.1212\/WNL.0000000000210247.","journal-title":"Neurology"},{"issue":"16","key":"1910_CR6","doi-asserted-by":"publisher","first-page":"1684","DOI":"10.1016\/j.scib.2021.02.018","volume":"66","author":"R Hua","year":"2021","unstructured":"Hua R, Ma Y, Li C, Zhong B, Xie W. Low levels of low-density lipoprotein cholesterol and cognitive decline. Sci Bull. 2021;66(16):1684\u201390. https:\/\/doi.org\/10.1016\/j.scib.2021.02.018.","journal-title":"Sci Bull"},{"issue":"10452","key":"1910_CR7","doi-asserted-by":"publisher","first-page":"572","DOI":"10.1016\/S0140-6736(24)01296-0","volume":"404","author":"G Livingston","year":"2024","unstructured":"Livingston G, Huntley J, Liu KY, et al. Dementia prevention, intervention, and care: 2024 report of the Lancet standing Commission. Lancet. 2024;404(10452):572\u2013628. https:\/\/doi.org\/10.1016\/S0140-6736(24)01296-0.","journal-title":"Lancet"},{"issue":"4","key":"1910_CR8","doi-asserted-by":"publisher","first-page":"979","DOI":"10.1111\/jgs.16975","volume":"69","author":"G Spencer-Bonilla","year":"2021","unstructured":"Spencer-Bonilla G, Chung S, Sarraju A, Heidenreich P, Palaniappan L, Rodriguez F. Statin use in older adults with stable atherosclerotic cardiovascular disease. J Am Geriatr Soc. 2021;69(4):979\u201385. https:\/\/doi.org\/10.1111\/jgs.16975.","journal-title":"J Am Geriatr Soc"},{"issue":"25","key":"1910_CR9","doi-asserted-by":"publisher","first-page":"e1082","DOI":"10.1161\/CIR.0000000000000625","volume":"139","author":"SM Grundy","year":"2019","unstructured":"Grundy SM, Stone NJ, Bailey AL. 2018 AHA\/ACC\/AACVPR\/AAPA\/ABC\/ACPM\/ADA\/AGS\/APhA\/ASPC\/NLA\/PCNA guideline on the management of blood cholesterol: a report of the American College of Cardiology\/American Heart Association Task Force on Clinical Practice Guidelines. Circulation. 2019;139(25):e1082\u2013143. https:\/\/doi.org\/10.1161\/CIR.0000000000000625.","journal-title":"Circulation"},{"key":"1910_CR10","doi-asserted-by":"publisher","unstructured":"10. Shepardson NE, Shankar GM, Selkoe DJ. Cholesterol level and statin use in Alzheimer disease: II. Review of human trials and recommendations. Arch Neurol. 2011;68(11):1385\u20131392. https:\/\/doi.org\/10.1001\/archneurol.2011.242.","DOI":"10.1001\/archneurol.2011.242"},{"key":"1910_CR11","doi-asserted-by":"publisher","unstructured":"11. van Vliet P, van de Water W, de Craen AJ, Westendorp RG. The influence of age on the association between cholesterol and cognitive function. Exp Gerontol. 2009;44(1\u20132):112\u2009\u2212\u200922. https:\/\/doi.org\/10.1016\/j.exger.2008.05.004.","DOI":"10.1016\/j.exger.2008.05.004"},{"key":"1910_CR12","doi-asserted-by":"publisher","unstructured":"12. Kivipelto M, Helkala EL, Laakso MP, et al. Midlife vascular risk factors and Alzheimer\u2019s disease in later life: longitudinal, population based study. BMJ. 2001;322(7300):1447-51. https:\/\/doi.org\/10.1136\/bmj.322.7300.1447.","DOI":"10.1136\/bmj.322.7300.1447"},{"issue":"5","key":"1910_CR13","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1001\/archneur.61.5.705","volume":"61","author":"C Reitz","year":"2004","unstructured":"Reitz C, Tang MX, Luchsinger J, Mayeux R. Relation of plasma lipids to Alzheimer disease and vascular dementia. Arch Neurol. 2004;61(5):705\u201314. https:\/\/doi.org\/10.1001\/archneur.61.5.705.","journal-title":"Arch Neurol"},{"issue":"8","key":"1910_CR14","doi-asserted-by":"publisher","first-page":"e498","DOI":"10.1016\/S2666-7568(21)00150-1","volume":"2","author":"M Iwagami","year":"2021","unstructured":"Iwagami M, Qizilbash N, Gregson J, et al. Blood cholesterol and risk of dementia in more than 1.8\u00a0million people over two decades: a retrospective cohort study. Lancet Healthy Longev. 2021;2(8):e498\u2013506. https:\/\/doi.org\/10.1016\/S2666-7568(21)00150-1.","journal-title":"Lancet Healthy Longev"},{"key":"1910_CR15","doi-asserted-by":"publisher","unstructured":"15. Schilling S, Tzourio C, Soumar\u00e9 A, et al. Differential associations of plasma lipids with incident dementia and dementia subtypes in the 3\u00a0C Study: a longitudinal, population-based prospective cohort study. PLoS Med. 2017;14(3):e1002265. https:\/\/doi.org\/10.1371\/journal.pmed.1002265.","DOI":"10.1371\/journal.pmed.1002265"},{"key":"1910_CR16","doi-asserted-by":"publisher","unstructured":"16. Ferguson EL, Zimmerman SC, Jiang C, et al. Independent associations of high-density lipoprotein cholesterol and triglyceride levels with Alzheimer\u2019s disease and related dementias. Alzheimers Dement. 2025;21(2):e14575. https:\/\/doi.org\/10.1002\/alz.14575.","DOI":"10.1002\/alz.14575"},{"issue":"6","key":"1910_CR17","doi-asserted-by":"publisher","first-page":"682","DOI":"10.1037\/neu0000335","volume":"31","author":"V Parthasarathy","year":"2017","unstructured":"Parthasarathy V, Frazier DT, Bettcher BM, et al. Triglycerides are negatively correlated with cognitive function in nondemented aging adults. Neuropsychology. 2017;31(6):682\u20138. https:\/\/doi.org\/10.1037\/neu0000335.","journal-title":"Neuropsychology"},{"issue":"3","key":"1910_CR18","doi-asserted-by":"publisher","DOI":"10.1007\/s11883-012-0307-3","volume":"15","author":"C Reitz","year":"2013","unstructured":"Reitz C. Dyslipidemia and the risk of Alzheimer\u2019s disease. Curr Atheroscler Rep. 2013;15(3):307. https:\/\/doi.org\/10.1007\/s11883-012-0307-3.","journal-title":"Curr Atheroscler Rep"},{"key":"1910_CR19","doi-asserted-by":"publisher","DOI":"10.3389\/fnagi.2020.00057","volume":"12","author":"FN Yang","year":"2020","unstructured":"Yang FN, Stanford M, Jiang X. Low cholesterol level linked to reduced semantic fuency performance and reduced gray matter volume in the medial temporal lobe. Front Aging Neurosci. 2020;12:57. https:\/\/doi.org\/10.3389\/fnagi.2020.00057.","journal-title":"Front Aging Neurosci"},{"issue":"22","key":"1910_CR20","doi-asserted-by":"publisher","first-page":"e2288","DOI":"10.1212\/wnl.0000000000207923","volume":"101","author":"Z Zhou","year":"2023","unstructured":"Zhou Z, Ryan J, Tonkin AM, et al. Association between triglycerides and risk of dementia in community-dwelling older adults: a prospective cohort study. Neurology. 2023;101(22):e2288\u201399. https:\/\/doi.org\/10.1212\/wnl.0000000000207923.","journal-title":"Neurology"},{"issue":"6","key":"1910_CR21","doi-asserted-by":"publisher","first-page":"1006","DOI":"10.1016\/j.neurobiolaging.2007.09.012","volume":"30","author":"A Solomon","year":"2009","unstructured":"Solomon A, K\u00e5reholt I, Ngandu T, et al. Serum total cholesterol, statins and cognition in non-demented elderly. Neurobiol Aging. 2009;30(6):1006\u20139. https:\/\/doi.org\/10.1016\/j.neurobiolaging.2007.09.012.","journal-title":"Neurobiol Aging"},{"issue":"1","key":"1910_CR22","doi-asserted-by":"publisher","first-page":"215","DOI":"10.3233\/jad-160826","volume":"56","author":"KJ Anstey","year":"2017","unstructured":"Anstey KJ, Ashby-Mitchell K, Peters R. Updating the evidence on the association between serum cholesterol and risk of late-life dementia: review and meta-analysis. J Alzheimers Dis. 2017;56(1):215\u201328. https:\/\/doi.org\/10.3233\/jad-160826.","journal-title":"J Alzheimers Dis"},{"issue":"1","key":"1910_CR23","doi-asserted-by":"publisher","DOI":"10.1186\/s12889-024-19164-8","volume":"24","author":"L Li","year":"2024","unstructured":"Li L, Zhuang L, Xu Z, et al. U-shaped relationship between non-high-density lipoprotein cholesterol and cognitive impairment in Chinese middle-aged and elderly: a cross-sectional study. BMC Public Health. 2024;24(1):1624. https:\/\/doi.org\/10.1186\/s12889-024-19164-8.","journal-title":"BMC Public Health"},{"issue":"1","key":"1910_CR24","doi-asserted-by":"publisher","DOI":"10.1186\/s13195-020-00731-1","volume":"12","author":"L Liu","year":"2020","unstructured":"Liu L, Zhang C, Lv X, et al. Sex-specific associations between lipids and cognitive decline in the middle-aged and elderly: a cohort study of Chinese adults. Alzheimers Res Ther. 2020;12(1):164. https:\/\/doi.org\/10.1186\/s13195-020-00731-1.","journal-title":"Alzheimers Res Ther"},{"issue":"1","key":"1910_CR25","doi-asserted-by":"publisher","first-page":"273","DOI":"10.3233\/JAD-121138","volume":"34","author":"Y Katsumata","year":"2013","unstructured":"Katsumata Y, Todoriki H, Higashiuesato Y. Very old adults with better memory function have higher low-density lipoprotein cholesterol levels and lower triglyceride to high-density lipoprotein cholesterol ratios: KOCOA project. J Alzheimers Dis. 2013;34(1):273\u20139. https:\/\/doi.org\/10.3233\/JAD-121138.","journal-title":"J Alzheimers Dis"},{"issue":"1","key":"1910_CR26","doi-asserted-by":"publisher","DOI":"10.1186\/s12937-024-00983-9","volume":"23","author":"H Huang","year":"2024","unstructured":"Huang H, Yang B, Yu R, Ouyang W, Tong J, Le Y. Very high high-density lipoprotein cholesterol may be associated with higher risk of cognitive impairment in older adults. Nutr J. 2024;23(1):79. https:\/\/doi.org\/10.1186\/s12937-024-00983-9.","journal-title":"Nutr J"},{"issue":"8","key":"1910_CR27","doi-asserted-by":"publisher","first-page":"e498","DOI":"10.1016\/s2666-7568(21)00150-1","volume":"2","author":"M Iwagami","year":"2021","unstructured":"Iwagami M, Qizilbash N, Gregson J, et al. Blood cholesterol and risk of dementia in more than 1\u00b78\u00a0million people over two decades: a retrospective cohort study. Lancet Healthy Longev. 2021;2(8):e498\u2013506. https:\/\/doi.org\/10.1016\/s2666-7568(21)00150-1.","journal-title":"Lancet Healthy Longev"},{"issue":"5","key":"1910_CR28","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.122.026833","volume":"12","author":"RS Rosenson","year":"2023","unstructured":"Rosenson RS, Cushman M, McKinley EC, et al. Association between triglycerides and incident cognitive impairment in black and white adults in the reasons for geographic and racial differences in stroke study. J Am Heart Assoc. 2023;12(5):e026833. https:\/\/doi.org\/10.1161\/JAHA.122.026833.","journal-title":"J Am Heart Assoc"},{"issue":"10","key":"1910_CR29","doi-asserted-by":"publisher","first-page":"e404","DOI":"10.1161\/ATV.0000000000000164","volume":"43","author":"LB Goldstein","year":"2023","unstructured":"Goldstein LB, Toth PP, Dearborn-Tomazos JL, et al. Aggressive LDL-C lowering and the brain: impact on risk for dementia and hemorrhagic stroke: a scientific statement from the American Heart Association. Arterioscler Thromb Vasc Biol. 2023;43(10):e404\u201342. https:\/\/doi.org\/10.1161\/ATV.0000000000000164.","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"9","key":"1910_CR30","doi-asserted-by":"publisher","first-page":"1053","DOI":"10.1001\/archinte.163.9.1053","volume":"163","author":"ZS Tan","year":"2003","unstructured":"Tan ZS, Seshadri S, Beiser A, et al. Plasma total cholesterol level as a risk factor for Alzheimer disease: the Framingham study. Arch Intern Med. 2003;163(9):1053\u20137. https:\/\/doi.org\/10.1001\/archinte.163.9.1053.","journal-title":"Arch Intern Med"},{"issue":"1","key":"1910_CR31","doi-asserted-by":"publisher","first-page":"215","DOI":"10.3233\/jad-160826","volume":"56","author":"KJ Anstey","year":"2017","unstructured":"Anstey KJ, Ashby-Mitchell K, Peters R. Updating the evidence on the association between serum cholesterol and risk of late-life dementia: review and meta-analysis. J Alzheimers Dis. 2017;56(1):215\u201328. https:\/\/doi.org\/10.3233\/jad-160826.","journal-title":"J Alzheimers Dis"},{"issue":"1","key":"1910_CR32","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-022-24153-1","volume":"12","author":"Y-B Lee","year":"2022","unstructured":"Lee Y-B, Kim MY, Han K, et al. Association between cholesterol levels and dementia risk according to the presence of diabetes and statin use: a nationwide cohort study. Sci Rep. 2022;12(1):19383. https:\/\/doi.org\/10.1038\/s41598-022-24153-1.","journal-title":"Sci Rep"},{"issue":"10","key":"1910_CR33","doi-asserted-by":"publisher","first-page":"1036","DOI":"10.15252\/embr.201439225","volume":"15","author":"MG Mart\u00edn","year":"2014","unstructured":"Mart\u00edn MG, Pfrieger F, Dotti CG. Cholesterol in brain disease: sometimes determinant and frequently implicated. EMBO Rep. 2014;15(10):1036\u201352. https:\/\/doi.org\/10.15252\/embr.201439225.","journal-title":"EMBO Rep"},{"issue":"6","key":"1910_CR34","doi-asserted-by":"publisher","DOI":"10.3390\/brainsci10060386","volume":"10","author":"O S\u00e1iz-Vazquez","year":"2020","unstructured":"S\u00e1iz-Vazquez O, Puente-Mart\u00ednez A, Ubillos-Landa S, Pacheco-Bonrostro J, Santab\u00e1rbara J. Cholesterol and Alzheimer\u2019s disease risk: a meta-meta-analysis. Brain Sci. 2020;10(6):386. https:\/\/doi.org\/10.3390\/brainsci10060386.","journal-title":"Brain Sci"},{"key":"1910_CR35","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1146\/annurev-neuro-091922-034237","volume":"46","author":"G Saher","year":"2023","unstructured":"Saher G. Cholesterol metabolism in aging and age-related disorders. Annu Rev Neurosci. 2023;46:59\u201378. https:\/\/doi.org\/10.1146\/annurev-neuro-091922-034237.","journal-title":"Annu Rev Neurosci"},{"issue":"5","key":"1910_CR36","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1016\/j.tins.2022.01.002","volume":"45","author":"D Li","year":"2022","unstructured":"Li D, Zhang J, Liu Q. Brain cell type-specific cholesterol metabolism and implications for learning and memory. Trends Neurosci. 2022;45(5):401\u201314. https:\/\/doi.org\/10.1016\/j.tins.2022.01.002.","journal-title":"Trends Neurosci"},{"key":"1910_CR37","doi-asserted-by":"publisher","DOI":"10.1155\/2012\/292598","volume":"2012","author":"M Orth","year":"2012","unstructured":"Orth M, Bellosta S. Cholesterol: its regulation and role in central nervous system disorders. Cholesterol. 2012;2012:292598. https:\/\/doi.org\/10.1155\/2012\/292598.","journal-title":"Cholesterol"},{"key":"1910_CR38","doi-asserted-by":"publisher","unstructured":"38. Shin KC, Ali Moussa HY, Park Y. Cholesterol imbalance and neurotransmission defects in neurodegeneration. Experimental & Molecular Medicine. 2024;56(8):1685\u20131690. https:\/\/doi.org\/10.1038\/s12276-024-01273-4.","DOI":"10.1038\/s12276-024-01273-4"},{"issue":"1","key":"1910_CR39","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1016\/j.arr.2012.06.007","volume":"12","author":"MA Castello","year":"2013","unstructured":"Castello MA, Soriano S. Rational heterodoxy: cholesterol reformation of the amyloid doctrine. Ageing Res Rev. 2013;12(1):282\u20138. https:\/\/doi.org\/10.1016\/j.arr.2012.06.007.","journal-title":"Ageing Res Rev"},{"issue":"5","key":"1910_CR40","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1038\/nrn3012","volume":"12","author":"G Di Paolo","year":"2011","unstructured":"Di Paolo G, Kim T-W. Linking lipids to Alzheimer\u2019s disease: cholesterol and beyond. Nat Rev Neurosci. 2011;12(5):284\u201396. https:\/\/doi.org\/10.1038\/nrn3012.","journal-title":"Nat Rev Neurosci"},{"issue":"4","key":"1910_CR41","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1038\/nn0403-345","volume":"6","author":"L Puglielli","year":"2003","unstructured":"Puglielli L, Tanzi RE, Kovacs DM. Alzheimer\u2019s disease: the cholesterol connection. Nat Neurosci. 2003;6(4):345\u201351. https:\/\/doi.org\/10.1038\/nn0403-345.","journal-title":"Nat Neurosci"},{"issue":"1","key":"1910_CR42","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/S0896-6273(03)00840-7","volume":"41","author":"B Wolozin","year":"2004","unstructured":"Wolozin B. Cholesterol and the biology of Alzheimer\u2019s disease. Neuron. 2004;41(1):7\u201310. https:\/\/doi.org\/10.1016\/S0896-6273(03)00840-7.","journal-title":"Neuron"},{"key":"1910_CR43","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1146\/annurev-biophys-062823-023436","volume":"53","author":"GA Pantelopulos","year":"2024","unstructured":"Pantelopulos GA, Abraham CB, Straub JE. Cholesterol and lipid rafts in the biogenesis of amyloid-\u03b2 protein and Alzheimer\u2019s disease. Annu Rev Biophys. 2024;53:455\u201386. https:\/\/doi.org\/10.1146\/annurev-biophys-062823-023436.","journal-title":"Annu Rev Biophys"},{"issue":"3","key":"1910_CR44","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1001\/archneur.59.3.378","volume":"59","author":"K Yaffe","year":"2002","unstructured":"Yaffe K, Barrett-Connor E, Lin F, Grady D. Serum lipoprotein levels, statin use, and cognitive function in older women. Arch Neurol. 2002;59(3):378\u201384. https:\/\/doi.org\/10.1001\/archneur.59.3.378.","journal-title":"Arch Neurol"},{"issue":"4","key":"1910_CR45","doi-asserted-by":"publisher","first-page":"748","DOI":"10.14283\/jpad.2023.59","volume":"10","author":"M Wang","year":"2023","unstructured":"Wang M, Wang Y, Zhang Y, et al. High intake of dietary cholesterol decreases the risk of all-cause dementia and AD dementia: a results from Framingham Offspring Cohort. J Prev Alzheimers Dis. 2023;10(4):748\u201355. https:\/\/doi.org\/10.14283\/jpad.2023.59.","journal-title":"J Prev Alzheimers Dis"},{"key":"1910_CR46","doi-asserted-by":"publisher","DOI":"10.3390\/jpm13020192","author":"P-S Chou","year":"2023","unstructured":"Chou P-S, Chen SC, Hsu C-Y, Liou L-M, Juan C-H, Lai C-L. The association between electronegative low-density lipoprotein cholesterol L5 and cognitive functions in patients with mild cognitive impairment. J Pers Med. 2023. https:\/\/doi.org\/10.3390\/jpm13020192.","journal-title":"J Pers Med"},{"key":"1910_CR47","doi-asserted-by":"publisher","DOI":"10.3389\/fnagi.2022.1021792","volume":"14","author":"R-C Tzeng","year":"2022","unstructured":"Tzeng R-C, Yang Y-W, Hsu K-C, Chang H-T, Chiu P-Y. Sum of boxes of the clinical dementia rating scale highly predicts conversion or reversion in predementia stages. Front Aging Neurosci. 2022;14:1021792. https:\/\/doi.org\/10.3389\/fnagi.2022.1021792.","journal-title":"Front Aging Neurosci"},{"issue":"4","key":"1910_CR48","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1159\/000066024","volume":"14","author":"KN Lin","year":"2002","unstructured":"Lin KN, Wang PN, Liu CY, Chen WT, Lee YC, Liu HC. Cutoff scores of the cognitive abilities screening instrument, Chinese version in screening of dementia. Dement Geriatr Cogn. 2002;14(4):176\u201382. https:\/\/doi.org\/10.1159\/000066024.","journal-title":"Dement Geriatr Cogn"},{"issue":"1, Part 2","key":"1910_CR49","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1016\/j.jfma.2020.07.001","volume":"120","author":"C-H Hung","year":"2021","unstructured":"Hung C-H, Hung G-U, Wei C-Y, Tzeng R-C, Chiu P-Y. Function-based dementia severity assessment for vascular cognitive impairment. J Formos Med Assoc. 2021;120(1, Part 2):533\u201341. https:\/\/doi.org\/10.1016\/j.jfma.2020.07.001.","journal-title":"J Formos Med Assoc"},{"issue":"3","key":"1910_CR50","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1111\/j.1365-2796.2004.01380.x","volume":"256","author":"B Winblad","year":"2004","unstructured":"Winblad B, Palmer K, Kivipelto M, et al. Mild cognitive impairment \u2013 beyond controversies, towards a consensus: report of the International Working Group on Mild Cognitive Impairment. J Intern Med. 2004;256(3):240\u20136. https:\/\/doi.org\/10.1111\/j.1365-2796.2004.01380.x.","journal-title":"J Intern Med"},{"key":"1910_CR51","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1016\/j.jalz.2011.03.005","volume":"7","author":"GM McKhann","year":"2011","unstructured":"McKhann GM, Knopman DS, Chertkow H, et al. The diagnosis of dementia due to Alzheimer\u2019s disease: recommendations from the National Institute on Ageing-Alzheimer\u2019s Association workgroups on diagnostic guidelines for Alzheimer\u2019s disease. Alzheimers Dement. 2011;7:263\u20139. https:\/\/doi.org\/10.1016\/j.jalz.2011.03.005.","journal-title":"Alzheimers Dement"},{"issue":"11","key":"1910_CR52","doi-asserted-by":"publisher","first-page":"2412","DOI":"10.1212\/WNL.43.11.2412-a","volume":"43","author":"JC Morris","year":"1993","unstructured":"Morris JC. The clinical dementia rating (CDR): current version and scoring rules. Neurology. 1993;43(11):2412\u20134.","journal-title":"Neurology"},{"issue":"1","key":"1910_CR53","doi-asserted-by":"publisher","DOI":"10.1186\/s12877-022-03287-x","volume":"22","author":"Y-C Chou","year":"2022","unstructured":"Chou Y-C, Tsou H-H, Chan D-CD, et al. Validation of clinical frailty scale in Chinese translation. BMC Geriatr. 2022;22(1):604. https:\/\/doi.org\/10.1186\/s12877-022-03287-x.","journal-title":"BMC Geriatr"},{"issue":"1","key":"1910_CR54","doi-asserted-by":"publisher","DOI":"10.1186\/s12937-024-00983-9","volume":"23","author":"H Huang","year":"2024","unstructured":"Huang H, Yang B, Yu R, Ouyang W, Tong J, Le Y. Very high high-density lipoprotein cholesterol may be associated with higher risk of cognitive impairment in older adults. Nutr J. 2024;23(1):79. https:\/\/doi.org\/10.1186\/s12937-024-00983-9.","journal-title":"Nutr J"},{"issue":"1","key":"1910_CR55","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1016\/j.arr.2012.06.007","volume":"12","author":"MA Castello","year":"2013","unstructured":"Castello MA, Soriano S. Rational heterodoxy: cholesterol reformation of the amyloid doctrine. Ageing Res Rev. 2013;12(1):282\u20138. https:\/\/doi.org\/10.1016\/j.arr.2012.06.007.","journal-title":"Ageing Res Rev"},{"issue":"1","key":"1910_CR56","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1038\/nrcardio.2015.124","volume":"13","author":"RS Rosenson","year":"2016","unstructured":"Rosenson RS, Brewer HB Jr., Ansell BJ, et al. Dysfunctional HDL and atherosclerotic cardiovascular disease. Nat Rev Cardiol. 2016;13(1):48\u201360. https:\/\/doi.org\/10.1038\/nrcardio.2015.124.","journal-title":"Nat Rev Cardiol"},{"key":"1910_CR57","doi-asserted-by":"publisher","unstructured":"57. Henderson VW, Guthrie JR, Dennerstein L. Serum lipids and memory in a population based cohort of middle age women. J Neurol Neurosurg Psychiatry. 2003;74(11):1530-5. https:\/\/doi.org\/10.1136\/jnnp.74.11.1530.","DOI":"10.1136\/jnnp.74.11.1530"},{"issue":"2","key":"1910_CR58","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1016\/j.jalz.2017.07.757","volume":"14","author":"MC Power","year":"2018","unstructured":"Power MC, Rawlings A, Sharrett AR, et al. Association of midlife lipids with 20-year cognitive change: a cohort study. Alzheimers Dement. 2018;14(2):167\u201377. https:\/\/doi.org\/10.1016\/j.jalz.2017.07.757.","journal-title":"Alzheimers Dement"},{"key":"1910_CR59","doi-asserted-by":"publisher","unstructured":"59. Bernath MM, Bhattacharyya S, Nho K, et al. Serum triglycerides in Alzheimer disease: Relation to neuroimaging and CSF biomarkers. Neurology. 2020;94(20):e2088-e2098. https:\/\/doi.org\/10.1212\/wnl.0000000000009436.","DOI":"10.1212\/wnl.0000000000009436"},{"issue":"4","key":"1910_CR60","doi-asserted-by":"publisher","first-page":"748","DOI":"10.14283\/jpad.2023.59","volume":"10","author":"M Wang","year":"2023","unstructured":"Wang M, Wang Y, Zhang Y, et al. High intake of dietary cholesterol decreases the risk of all-cause dementia and AD dementia: a results from Framingham Offspring Cohort. J Prev Alzheimers Dis. 2023;10(4):748\u201355. https:\/\/doi.org\/10.14283\/jpad.2023.59.","journal-title":"J Prev Alzheimers Dis"}],"container-title":["Alzheimer's Research &amp; Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13195-025-01910-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13195-025-01910-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13195-025-01910-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,30]],"date-time":"2025-12-30T02:21:56Z","timestamp":1767061316000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s13195-025-01910-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,26]]},"references-count":60,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["1910"],"URL":"https:\/\/doi.org\/10.1186\/s13195-025-01910-8","relation":{},"ISSN":["1758-9193"],"issn-type":[{"value":"1758-9193","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,26]]},"assertion":[{"value":"25 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 November 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All data were retrospectively and anonymously analyzed. The study was approved by the Committee for Medical Research Ethics of Show Chwan Memorial Hospital (SCMH_IRB No: IRB1081006), and the need for informed consent was waived.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"<!--Emphasis Type='Bold' removed-->Ethics approval and consent to participants"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"The authors declare no conflicts of interest related to this work.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}],"article-number":"273"}}